Healthcare costs of patients with cancer stratified by Khorana score risk levels-Reference-Cited by-同舟云学术

Healthcare costs of patients with cancer stratified by Khorana score risk levels

Published:2021-01-01 Issue:1 Volume:24 Page:866-873
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Khorana Alok A.¹,Kuderer Nicole M.²,McCrae Keith¹,Milentijevic Dejan³,Germain Guillaume⁴^ORCID,Laliberté François⁴^ORCID,MacKnight Sean D.⁴^ORCID,Lefebvre Patrick⁴,Lyman Gary H.⁵^ORCID,Streiff Michael B.⁶

Affiliation:

1. Cleveland Clinic and Case Comprehensive Cancer Center, Cleveland, OH, USA

2. Advanced Cancer Research Group., Seattle, WA, USA

3. Janssen Scientific Affairs, LLC, Titusville, NJ, USA

4. Groupe d’Analyse, Ltée, Montreal, Canada

5. Fred Hutchinson Cancer Research Center, and University of Washington, Seattle, WA, USA

6. Division of Hematology, Department of Medicine, John Hopkins University School of Medicine, Baltimore, MD, USA

Funder

Janssen Scientific Affairs, LLC

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2021.1948681

Reference48 articles.

1. Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis

2. Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study

3. Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism

4. Direct Medical Costs Attributable to Cancer-Associated Venous Thromboembolism: A Population-Based Longitudinal Study

5. Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary thromboprophylaxis in cancer outpatients – real-world evidence;Journal of Thrombosis and Thrombolysis;2024-04-20